Ads
related to: t-cell therapy- Resources & Support
Find Helpful Resources & Support
For An RR Multiple Myeloma Option.
- BCMA Targeting Option
Learn More About A Treatment Option
That Targets BCMA In RRMM Therapy.
- Resources & Support
Search results
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 3 days agoTILT-123 is an oncolytic adenovirus featuring tumour necrosis factor alpha (TNFα) and interleukin-2...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 6 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 7 days agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
...Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination ...
Benzinga via Yahoo Finance· 3 days agoCoya Therapeutics Inc (NASDAQ:COYA) is a clinical-stage biotechnology company developing treatments...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
CBS 47 Fresno· 6 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly ...
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 11 hours agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Study reveals circadian clock can be leveraged to enhance cancer immunotherapy
Medical Xpress· 2 days agoA multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock—the biological pacemaker that governs daily rhythms in physiological processes ...
Compugen hits milestone with AstraZeneca cancer trial By Investing.com
Investing.com· 5 hours agoThe trial is a crucial step in evaluating the drug as a first-line treatment for a specific type of...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 6 days agoThe study, which includes the company's CXCR4 inhibitor motixafortide, showed an increase in CD8+ T-...
Biotech Stocks Facing FDA Decision In June 2024
RTT News· 18 hours agoNotably, in June, Eli Lilly's investigational antibody therapy Donanemab for treating early Alzheimer's will be reviewed by an advisory panel. Before delving into the drugs ...
